SelectQuote (NYSE:SLQT) Hits New 52-Week High – Should You Buy?
by Danessa Lincoln · The Markets DailySelectQuote, Inc. (NYSE:SLQT – Get Free Report)’s stock price reached a new 52-week high during trading on Tuesday. The stock traded as high as $8.07 and last traded at $7.0950, with a volume of 38,956 shares traded. The stock had previously closed at $0.38.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on the stock. Wall Street Zen upgraded shares of SelectQuote to a “hold” rating in a report on Saturday. Zacks Research upgraded SelectQuote from a “strong sell” rating to a “hold” rating in a research note on Monday, October 26th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of SelectQuote in a report on Friday. One research analyst has rated the stock with a Strong Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $3.00.
View Our Latest Report on SelectQuote
SelectQuote Price Performance
The company has a current ratio of 7.48, a quick ratio of 7.48 and a debt-to-equity ratio of 1.16. The business has a 50-day moving average of $0.41 and a 200 day moving average of $0.72. The firm has a market capitalization of $1.29 billion, a PE ratio of -240.40 and a beta of 2.01.
SelectQuote (NYSE:SLQT – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.12. SelectQuote had a net margin of 4.61% and a return on equity of 22.48%. The firm had revenue of $280.01 million for the quarter, compared to the consensus estimate of $277.91 million. As a group, research analysts anticipate that SelectQuote, Inc. will post -0.25 EPS for the current fiscal year.
Insider Activity at SelectQuote
In other news, President Robert Grant acquired 79,801 shares of SelectQuote stock in a transaction on Friday, November 6th. The stock was acquired at an average cost of $0.51 per share, with a total value of $40,698.51. Following the transaction, the president owned 3,386,491 shares of the company’s stock, valued at approximately $1,727,110.41. This trade represents a 2.41% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Donald Hawks, III acquired 223,402 shares of SelectQuote stock in a transaction on Monday, November 9th. The stock was purchased at an average cost of $0.46 per share, with a total value of $102,764.92. Following the completion of the transaction, the director directly owned 763,214 shares in the company, valued at $351,078.44. This represents a 41.39% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased 919,905 shares of company stock valued at $446,916 over the last three months. Insiders own 11.60% of the company’s stock.
Hedge Funds Weigh In On SelectQuote
Several hedge funds have recently modified their holdings of SLQT. Cetera Investment Advisers bought a new position in shares of SelectQuote in the third quarter valued at approximately $43,000. Marshall Wace LLP boosted its position in SelectQuote by 213.8% in the third quarter. Marshall Wace LLP now owns 866,887 shares of the company’s stock worth $355,000 after purchasing an additional 590,606 shares during the last quarter. Commonwealth Equity Services LLC boosted its position in SelectQuote by 541.1% in the third quarter. Commonwealth Equity Services LLC now owns 181,939 shares of the company’s stock worth $74,000 after purchasing an additional 153,562 shares during the last quarter. SMH Capital Advisors Inc. purchased a new position in SelectQuote in the third quarter worth $47,000. Finally, Fragasso Financial Advisors Inc bought a new position in SelectQuote in the 3rd quarter valued at $61,000. Institutional investors own 34.59% of the company’s stock.
SelectQuote Company Profile
SelectQuote, Inc. operates a direct-to-consumer insurance distribution platform that helps consumers compare coverage from multiple insurance providers. Its licensed agents assist customers with evaluating options and selecting policies. The company offers Medicare-related products, including Medicare Advantage, Medicare Supplement and prescription drug plans, as well as life, auto and home insurance. Its services also include SelectRx, which provides pharmacy and medication-management services.
Further Reading
- Five stocks we like better than SelectQuote
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
- Tyson Foods’ Earnings Beat Hides a Warning for Consumer Staples Dividend Investors
- 3 Stocks in an Overlooked Corner of Infrastructure With Hundreds of Billions at Stake